Los Angeles Capital Management LLC Invests $1.19 Million in Oscar Health, Inc. $OSCR

Los Angeles Capital Management LLC acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 55,317 shares of the company’s stock, valued at approximately $1,186,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of OSCR. Thrive Capital Management LLC lifted its position in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Cerity Partners LLC bought a new stake in Oscar Health during the 1st quarter valued at about $132,000. Xponance Inc. boosted its position in Oscar Health by 7.1% in the 1st quarter. Xponance Inc. now owns 15,423 shares of the company’s stock valued at $202,000 after buying an additional 1,029 shares during the period. CWM LLC boosted its position in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after buying an additional 1,078 shares during the period. Finally, Larson Financial Group LLC grew its stake in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after acquiring an additional 2,512 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on OSCR. Wells Fargo & Company lifted their price target on shares of Oscar Health from $10.00 to $14.00 and gave the company an “underweight” rating in a research note on Tuesday, October 7th. Barclays raised their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a report on Monday. Piper Sandler decreased their target price on Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a research report on Thursday, August 14th. UBS Group upped their target price on Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a report on Friday, November 7th. Finally, Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. Six investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Reduce” and an average price target of $13.57.

Oscar Health Stock Performance

Shares of NYSE:OSCR opened at $15.08 on Thursday. The firm has a 50 day moving average of $19.04 and a 200 day moving average of $16.87. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $3.90 billion, a price-to-earnings ratio of -13.46 and a beta of 1.88. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.80.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The business had revenue of $2.93 billion for the quarter, compared to analysts’ expectations of $3.09 billion. During the same quarter last year, the firm earned ($0.22) EPS. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Oscar Health has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 395,000 shares of the firm’s stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the sale, the insider owned 501,148 shares of the company’s stock, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is owned by company insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.